コンテンツへスキップ
Merck

Adverse drug reactions induced by valproic acid.

Clinical biochemistry (2013-06-25)
Radu M Nanau, Manuela G Neuman
要旨

Valproic acid is a widely-used first-generation antiepileptic drug, prescribed predominantly in epilepsy and psychiatric disorders. VPA has good efficacy and pharmacoeconomic profiles, as well as a relatively favorable safety profile. However, adverse drug reactions have been reported in relation with valproic acid use, either as monotherapy or polytherapy with other antiepileptic drugs or antipsychotic drugs. This systematic review discusses valproic acid adverse drug reactions, in terms of hepatotoxicity, mitochondrial toxicity, hyperammonemic encephalopathy, hypersensitivity syndrome reactions, neurological toxicity, metabolic and endocrine adverse events, and teratogenicity.

材料
製品番号
ブランド
製品内容

USP
バルプロ酸, United States Pharmacopeia (USP) Reference Standard
Supelco
バルプロ酸 溶液, 1.0 mg/mL in methanol, ampule of 1 mL, certified reference material, Cerilliant®
Sigma-Aldrich
2-プロピルペンタン酸
Supelco
バルプロ酸, Pharmaceutical Secondary Standard; Certified Reference Material
バルプロ酸, European Pharmacopoeia (EP) Reference Standard